Inside the tumor: AI cracks five hidden cell types to stop cancer’s comeback Scientists have developed a new AI tool which could be integrated into cancer diagnostics to better inform treatment.

A new cancer drug candidate developed by Lawrence Livermore National Lab, BridgeBio Oncology Therapeutics and the Frederick National Laboratory for Cancer Research shows the ability to block tumor ...

Previous studies have shown that chemotherapy is most effective when the tumor cells are dividing. But this finding has been hardly used at all in clinical treatment to date.

The experimental medication, called MT-125, has received approval from the FDA to move to clinical trials as a possible first-line treatment for the most aggressive form of the brain cancer.